Two of four experimental treatments being tested in the world's second-largest Ebola outbreak will now be offered to all patients after showing promise in saving lives, scientists and health officials announce.
Two of four experimental treatments being tested in the world's second-largest Ebola outbreak will now be offered to all patients after showing promise in saving lives, scientists and health officials announced Monday.
"It means we do have now what looks like [two] treatments for a disease which, not too long ago, we really had no therapeutic approach at all," Fauci told reporters during a telephone briefing Monday, stressing that more research needs to be done. REGN-EB3 is made by American biotechnology company Regeneron Pharmaceuticals, and mAb114 was developed by the U.S. National Institute of Allergy and Infectious Diseases, which licensed production last year to American biotechnology company Ridgeback Biotherapeutics.
This is the 10th outbreak of the disease in the Democratic Republic of the Congo and the most severe in the country since 1976, when scientists identified the deadly virus near the Ebola River.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Two experimental Ebola treatments being tested in Congo show promiseOutbreak of the virus spreading in eastern Democratic Republic of Congo since August 2018 is the world's second largest in history.
Read more »
Two Ebola drugs found to increase survival ratesScientists has come a step closer to an effective treatment for Ebola after two drugs in a clinical trial were found to significantly boost survival rates
Read more »
Two Experimental Ebola Drugs Reduce Mortality RateTwo experimental Ebola drugs significantly improve a patient’s chance of surviving the virus, according to preliminary data from a medical trial, offering fresh hope for stopping an outbreak of the disease in the Democratic Republic of Congo.
Read more »
New Drugs Cured 2 Ebola Patients: DoctorsEarlier this week, preliminary results from two trials in Congo suggested that the two drugs significantly reduced the risk of death from Ebola.
Read more »
New drugs could cure Ebola, clinical trial suggests
Read more »